James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 379,279 shares at $12.76 ($4.8M) on 2016-06-01, disclosed to the SEC on 2016-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 35 | $0 | 0.0% |
| 2 | $11.43 | 56,739 | $649K | 13.4% |
| 3 | $12.76 | 127,691 | $1.6M | 33.8% |
| 4 | $12.76 | 127,691 | $1.6M | 33.8% |
| 5 | $13.22 | 8,233 | $109K | 2.3% |
| 6 | $13.26 | 28,797 |
| $382K |
| 7.9% |
| 7 | $14.11 | 23,890 | $337K | 7.0% |
| 8 | $14.22 | 6,203 | $88K | 1.8% |
| Total | $12.72 avg | 379,279 | $4.8M | 100% |
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |